Medtronic: a mixed start to the year.
(CercleFinance.com) - Before trading in Wall Street on Tuesday Medtronic released Q1 results that included EPS that was up 8 cents at 74 cents.
Excluding extraordinary items, EPS came in at 1.12 dollar, i.e. 4 cents more than the consensus.
However, sales disappointed, with revenues increasing by less than expected to 7.39 billion dollars, after 7.17 billion dollars in Q1 and 7.45 billion dollars expected by the consensus.
Medtronic expects sales growth of between 4% and 5% over the current fiscal year.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
Excluding extraordinary items, EPS came in at 1.12 dollar, i.e. 4 cents more than the consensus.
However, sales disappointed, with revenues increasing by less than expected to 7.39 billion dollars, after 7.17 billion dollars in Q1 and 7.45 billion dollars expected by the consensus.
Medtronic expects sales growth of between 4% and 5% over the current fiscal year.
Copyright (c) 2017 CercleFinance.com. All rights reserved.